Disclosure 0001366074-26-000006-5

SEC FORM 4

$208,333.04

Inhibrx Biosciences, Inc. (INBX)

Purchase of 2,451 shares at $84.9992 per share.

Reporting Person Lappe Mark · Officer Title Chief Executive Officer · Transaction Code P

Traded Oct 14, 2026 · Disclosed Oct 14, 2026

Source: SEC Form 4 · 0001366074-26-000006 · filed 2026-10-14 · View filing →

Composed from the Form 4 as filed with the SEC. Share counts, prices and dates are the filing's own; the disclosure lag is counted in business days from the transaction date to the filing date. What is a Form 4?

Cite this card

Desq Long. "Inhibrx Biosciences, Inc. (INBX)." Disclosed 2026-10-14. https://desqlong.com/cards/0001366074-26-000006-5 (retrieved 2026-10-15).